Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
But the right dose and how often to give it depends on the patient
a landmark study in the Journal of Investigative Dermatology demonstrated that topical or intraperitoneal thymosin beta-4 increased rat wound reepithelialization by 42% at day 4 and up to 61% at day 7 versus saline controls, with increased collagen deposition and angiogenesis also documented
The licence holder for the product is Hameln pharmaceuticals, and the product licence number is: PL 01502/0003R
Megadosing by doing frequent injections when you dont actually need it can lead to side effects like itchy rash, anxiety, and rapid heartbeat
Long-term repair (such as nerve healing) still takes time, but the fresh supply of B12 starts several processes right away
So, envisioning a way ahead, to summarize: BPC-157 may be beneficial in healing orthopaedic injuries and once it is approved for human therapeutic use by any governmental regulatory health authority (FDA is just one of many) it would not be a non-approved substance under class S-0 of the WADA Code, and therefore not be banned
